| Financial Year |
March 31 2023 |
| Monetary Funds |
26,254,546,523.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
330,645,778.91 |
| Accounts Receivable |
22,487,212,303.88 |
| Advances to Suppliers |
6,928,004,204.55 |
| Other Receivables |
2,705,299,726.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,191,100,896.79 |
| Inventories |
5,251,507,025.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
249,000,000.00 |
| Other Current Assets |
2,905,496,676.57 |
| Total Current Assets |
67,324,262,589.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
197,615,255.01 |
| Long-term Equity Investment |
13,013,569,110.79 |
| Investment Properties |
100,607,455.30 |
| Fixed Assetes |
257,681,227,275.82 |
| Under-construction Projects |
65,781,474,871.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,651,135,679.46 |
| R&D expenses |
364,691,441.23 |
| Goodwill |
1,156,253,199.42 |
| Long-Term Deferred and Prepaid Expenses |
1,244,728,276.17 |
| Deferred Income Tax Assets |
691,146,202.49 |
| Other Non-Current Assets |
1,737,162,189.52 |
| Sub-Total of Non-Current Assets |
355,746,793,098.11 |
| Total Assets |
423,071,055,687.43 |
| Short-Term Loans |
44,763,347,004.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,501,566,797.32 |
| Accounts Payable |
21,348,759,566.98 |
| Accounts Received In Advance |
112,300,552.22 |
| Employee Compensation Payable |
3,057,465,570.99 |
| Taxes Payable |
1,923,830,626.96 |
| Interest Payable |
-- |
| Dividend Payable |
2,420,862,605.68 |
| Other payables |
12,398,855,370.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,285,672,571.46 |
| Other Current Liabilities |
5,914,417,068.34 |
| Sub-Total of Current Liabilities |
121,764,190,163.34 |
| Long-term Loans |
156,162,944,543.53 |
| Bonds Payable |
6,828,763,184.47 |
| Long-Term Accounts Payable |
4,940,561,852.38 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,123,540,015.19 |
| Deferred Income Tax Liabilities |
633,033,302.75 |
| Other Non-Current Liabilities |
14,357,703,840.84 |
| Sub-Total of Non-Current Liabilities |
188,540,722,199.52 |
| Total Liabilities |
310,304,912,362.86 |
| Paid-In Capital(Or Share Stock) |
17,835,619,082.00 |
| Capital Surplus |
543,194,515.36 |
| Surplus Reserve |
5,553,952,375.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
20,588,703,581.46 |
| Minority Stockholder's Interest |
66,581,783,654.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
46,184,359,669.90 |
| Owner's Equity（Stockholder's Equity） |
112,766,143,324.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
423,071,055,687.43 |
